Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Shares Cross Above 50-Day Moving Average - Here's Why

Key Points

• Senseonics shares rose 12.1%, trading at $9.34 after crossing above the 50-day moving average of $9.16; volume reached nearly 1 million shares.
• Analyst sentiment remains mixed, with a consensus “Hold” rating and an average price target of $13.00. Targets range from $10.00 at Barclays to $18.00 at Mizuho, while TD Cowen maintains a $15.00 target and Buy rating.
• The company continues to report significant losses, including quarterly EPS of negative $0.63 versus an expected negative $0.55 and a negative net margin of 225.09%; however, director Douglas Roeder purchased approximately $125,000 of shares.

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $9.16 and traded as high as $9.39. Senseonics Holdings, Inc. Common Stock shares last traded at $9.34, with a volume of 998,843 shares.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. TD Cowen reissued a "buy" rating and issued a $15.00 target price on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday. Mizuho reduced their price target on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an "outperform" rating for the company in a research report on Wednesday, July 15th. Wall Street Zen raised shares of Senseonics Holdings, Inc. Common Stock from a "strong sell" rating to a "sell" rating in a research note on Saturday, August 8th. Barclays initiated coverage on shares of Senseonics Holdings, Inc. Common Stock in a research note on Wednesday, October 7th. They set an "equal weight" rating and a $10.00 price target for the company. Finally, Weiss Ratings downgraded shares of Senseonics Holdings, Inc. Common Stock from a "sell (d-)" rating to a "sell (e+)" rating in a report on Thursday, October 22nd. Three research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Senseonics Holdings, Inc. Common Stock has a consensus rating of "Hold" and an average price target of $13.00.

Senseonics Holdings, Inc. Common Stock Trading Up 12.1%

The business has a 50 day moving average of $9.16 and a two-hundred day moving average of $7.18. The company has a current ratio of 6.74, a quick ratio of 6.40 and a debt-to-equity ratio of 0.62. The firm has a market cap of $390.41 million, a P/E ratio of -4.19 and a beta of 1.02.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The business had revenue of $14.48 million for the quarter. Analysts predict that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current year.

Insider Buying and Selling at Senseonics Holdings, Inc. Common Stock

In other news, Director Douglas Roeder bought 13,953 shares of the stock in a transaction dated Wednesday, August 19th. The shares were bought at an average price of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the purchase, the director owned 171,191 shares in the company, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 4.70% of the company's stock.

Institutional Trading of Senseonics Holdings, Inc. Common Stock

Institutional investors have recently added to or reduced their stakes in the company. Integrated Wealth Concepts LLC bought a new stake in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at about $36,000. Kestra Advisory Services LLC bought a new position in Senseonics Holdings, Inc. Common Stock during the first quarter worth about $68,000. The Manufacturers Life Insurance Company bought a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth about $65,000. State of Wyoming bought a new position in Senseonics Holdings, Inc. Common Stock during the second quarter worth about $67,000. Finally, Cetera Investment Advisers acquired a new stake in Senseonics Holdings, Inc. Common Stock in the 1st quarter worth about $85,000. 12.36% of the stock is currently owned by institutional investors.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company's primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.